The impact of pre-analytical factors on plasma biomarkers for Alzheimer's disease: The ASPREE Healthy Ageing Biobank
Following standard operating procedures, AD biomarkers can be measured in plasma from biobanks stored for up to 13 years, with minimal impact from long-term storage or other pre-analytical factors.
Authors
- Anne M. Murray (ORCID: https://orcid.org/0000-0002-2787-8433)
- Alice Owen (ORCID: https://orcid.org/0000-0002-4807-6069)
- Jo Wrigglesworth (ORCID: https://orcid.org/0000-0002-9251-4775)
- Zimu Wu (ORCID: https://orcid.org/0000-0003-1010-0462)
- Robyn L. Woods (ORCID: https://orcid.org/0000-0003-1249-6149)
- James Phung
- Joanne Ryan (ORCID: https://orcid.org/0000-0002-7039-6325)
- Michelle M. Mielke (ORCID: https://orcid.org/0000-0001-7177-1185)
- Danni Li (ORCID: https://orcid.org/0000-0002-0608-2831)
Institutions
- University of Minnesota (US)
- Monash Health (AU)
- Berman Center for Outcomes and Clinical Research (US)
- Hennepin Healthcare Research Institute (US)
- Wake Forest University (US)
- Monash University (AU)
Publication Details
- Journal
- The Journal of Prevention of Alzheimer s Disease
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1016/j.tjpad.2025.100058
- Citations
- 5
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 7.36
Funders
- National Institutes of Health